| Profile | GDS5420 / 38069_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 636.86 | 71 |
| GSM1296119 | B_lesional_pre-dose | 245.29 | 55 |
| GSM1296076 | C_lesional_pre-dose | 217.68 | 55 |
| GSM1296092 | D_lesional_pre-dose | 369.63 | 63 |
| GSM1296103 | E_lesional_pre-dose | 498.23 | 67 |
| GSM1296078 | F_lesional_pre-dose | 276.75 | 59 |
| GSM1296107 | G_lesional_pre-dose | 247.14 | 55 |
| GSM1296109 | H_lesional_pre-dose | 393.92 | 63 |
| GSM1296080 | I_lesional_pre-dose | 733.56 | 74 |
| GSM1296090 | J_lesional_pre-dose | 315.65 | 61 |
| GSM1296074 | K_lesional_pre-dose | 176.62 | 53 |
| GSM1296111 | L_lesional_pre-dose | 188.04 | 50 |
| GSM1296099 | M_lesional_pre-dose | 416.31 | 64 |
| GSM1296086 | O_lesional_pre-dose | 315.33 | 61 |
| GSM1296117 | P_lesional_pre-dose | 288.13 | 58 |
| GSM1296113 | Q_lesional_pre-dose | 235.26 | 53 |
| GSM1296096 | R_lesional_pre-dose | 402.25 | 64 |
| GSM1296105 | S_lesional_pre-dose | 400.12 | 63 |
| GSM1296098 | T_lesional_pre-dose | 596.5 | 70 |
| GSM1296101 | U_lesional_pre-dose | 586.78 | 70 |
| GSM1296121 | V_lesional_pre-dose | 251.58 | 56 |
| GSM1296088 | W_lesional_pre-dose | 415 | 65 |
| GSM1296082 | X_lesional_pre-dose | 335.03 | 62 |
| GSM1296115 | Y_lesional_pre-dose | 280.52 | 58 |
| GSM1296084 | Z_lesional_pre-dose | 415.72 | 65 |
| GSM1296072 | B_lesional_day8 | 250.9 | 55 |
| GSM1296069 | L_lesional_day8 | 208.88 | 51 |
| GSM1296071 | P_lesional_day8 | 302.53 | 58 |
| GSM1296070 | Y_lesional_day8 | 263.38 | 56 |
| GSM1296073 | V_lesional_day8 | 244.91 | 56 |
| GSM1296034 | A_lesional_day15 | 849.8 | 76 |
| GSM1296041 | G_lesional_day15 | 245.43 | 56 |
| GSM1296035 | R_lesional_day15 | 367.04 | 62 |
| GSM1296038 | U_lesional_day15 | 391.74 | 64 |
| GSM1296047 | B_lesional_day15 | 278.39 | 57 |
| GSM1296039 | E_lesional_day15 | 192.92 | 52 |
| GSM1296042 | H_lesional_day15 | 227.92 | 53 |
| GSM1296043 | L_lesional_day15 | 252.87 | 55 |
| GSM1296037 | M_lesional_day15 | 420.82 | 64 |
| GSM1296046 | P_lesional_day15 | 206.93 | 51 |
| GSM1296044 | Q_lesional_day15 | 216.16 | 52 |
| GSM1296045 | Y_lesional_day15 | 283.98 | 57 |
| GSM1296025 | C_lesional_day15 | 413.41 | 65 |
| GSM1296033 | D_lesional_day15 | 495.45 | 67 |
| GSM1296027 | I_lesional_day15 | 502.31 | 68 |
| GSM1296032 | J_lesional_day15 | 374 | 62 |
| GSM1296024 | K_lesional_day15 | 375.77 | 63 |
| GSM1296031 | W_lesional_day15 | 403.99 | 63 |
| GSM1296028 | X_lesional_day15 | 423.93 | 65 |
| GSM1296029 | Z_lesional_day15 | 565.09 | 69 |
| GSM1296026 | F_lesional_day15 | 377.78 | 64 |
| GSM1296030 | O_lesional_day15 | 587.88 | 70 |
| GSM1296040 | S_lesional_day15 | 581.22 | 70 |
| GSM1296036 | T_lesional_day15 | 575.28 | 69 |
| GSM1296048 | V_lesional_day15 | 286.34 | 58 |
| GSM1296059 | A_lesional_day43 | 404.13 | 64 |
| GSM1296066 | G_lesional_day43 | 235.4 | 54 |
| GSM1296060 | R_lesional_day43 | 389.74 | 63 |
| GSM1296063 | U_lesional_day43 | 252.47 | 56 |
| GSM1296064 | E_lesional_day43 | 298.45 | 60 |
| GSM1296067 | H_lesional_day43 | 333.5 | 60 |
| GSM1296062 | M_lesional_day43 | 556.67 | 69 |
| GSM1296068 | Q_lesional_day43 | 219 | 52 |
| GSM1296050 | C_lesional_day43 | 219.66 | 54 |
| GSM1296057 | D_lesional_day43 | 356.32 | 62 |
| GSM1296052 | I_lesional_day43 | 532.53 | 69 |
| GSM1296054 | J_lesional_day43 | 432.87 | 65 |
| GSM1296049 | K_lesional_day43 | 296.42 | 59 |
| GSM1296055 | W_lesional_day43 | 299.79 | 58 |
| GSM1296053 | X_lesional_day43 | 578.15 | 70 |
| GSM1296058 | Z_lesional_day43 | 525.54 | 68 |
| GSM1296051 | F_lesional_day43 | 248.36 | 57 |
| GSM1296056 | O_lesional_day43 | 437.35 | 66 |
| GSM1296065 | S_lesional_day43 | 254.94 | 56 |
| GSM1296061 | T_lesional_day43 | 644.33 | 71 |
| GSM1296095 | A_non-lesional_pre-dose | 251.74 | 56 |
| GSM1296120 | B_non-lesional_pre-dose | 202.8 | 51 |
| GSM1296077 | C_non-lesional_pre-dose | 312.08 | 60 |
| GSM1296093 | D_non-lesional_pre-dose | 510.61 | 67 |
| GSM1296104 | E_non-lesional_pre-dose | 244.87 | 55 |
| GSM1296079 | F_non-lesional_pre-dose | 346.63 | 62 |
| GSM1296108 | G_non-lesional_pre-dose | 247.17 | 55 |
| GSM1296110 | H_non-lesional_pre-dose | 289.77 | 57 |
| GSM1296081 | I_non-lesional_pre-dose | 770.77 | 75 |
| GSM1296091 | J_non-lesional_pre-dose | 263.35 | 58 |
| GSM1296075 | K_non-lesional_pre-dose | 170.4 | 51 |
| GSM1296112 | L_non-lesional_pre-dose | 225.36 | 52 |
| GSM1296100 | M_non-lesional_pre-dose | 497.54 | 67 |
| GSM1296087 | O_non-lesional_pre-dose | 502.71 | 68 |
| GSM1296118 | P_non-lesional_pre-dose | 239.28 | 54 |
| GSM1296114 | Q_non-lesional_pre-dose | 233.34 | 53 |
| GSM1296097 | R_non-lesional_pre-dose | 377.18 | 63 |
| GSM1296106 | S_non-lesional_pre-dose | 360.14 | 61 |
| GSM1296102 | U_non-lesional_pre-dose | 500.52 | 67 |
| GSM1296122 | V_non-lesional_pre-dose | 282.03 | 57 |
| GSM1296089 | W_non-lesional_pre-dose | 343.26 | 61 |
| GSM1296083 | X_non-lesional_pre-dose | 569.87 | 69 |
| GSM1296116 | Y_non-lesional_pre-dose | 190.9 | 49 |
| GSM1296085 | Z_non-lesional_pre-dose | 549.89 | 69 |